Adversarial Injection · Chloroacetaldehyde VCM Byproduct / Pharmaceutical Imidazole / Water Treatment · Attack #242

Chloroacetaldehyde (ClCH₂CHO; CAS 107-20-0; MW 78.50 g/mol; BP 85.5°C) Reactive Alkylating Aldehyde / NIOSH Ca — VCM Cracking Furnace Byproduct (Westlake Chemical Lake Charles LA; RAE MiniRAE 3000 PID), Pharmaceutical Imidazole Synthesis / Glycine Cyclization (Lonza Visp Switzerland; Dräger X-am 5000), and Industrial Water Treatment Biocide (SUEZ Water Technologies; MSA ALTAIR 4X) — OSHA PEL 1 ppm Ceiling (Table Z-1; 1971; Same as ACGIH) vs ACGIH TLV-C 1 ppm Ceiling (2024; Same as OSHA; No Limit-Type Mismatch) vs NIOSH Ca (No REL; Etheno-DNA Adducts 1,N6-eA + 3,N4-eC Shared with Vinyl Chloride IARC Group 1 Hepatic Angiosarcoma Mechanism): AI Prompt Injection via Downward Pixel Perturbation — FIRST Chloroacetaldehyde Etheno-DNA IARC-Group-1-Mechanism AI Attack

Chloroacetaldehyde (ClCH₂CHO; α-chloroacetaldehyde; 2-chloroacetaldehyde; CAS 107-20-0; MW 78.50 g/mol; BP 85.5°C; VP ~90 mmHg at 20°C; flash point 88°C; water-miscible; NIOSH Ca potential occupational carcinogen; no established NIOSH REL; reduce to lowest feasible concentration) presents an adversarial AI attack angle unique in the Glyphward portfolio: the regulatory limits (OSHA PEL 1 ppm ceiling; ACGIH TLV-C 1 ppm ceiling — identical value, identical limit type, no numerical gap, no limit-type mismatch) are structurally in agreement, but the attack exploits the mechanistic linkage between chloroacetaldehyde and vinyl chloride hepatic angiosarcoma (IARC Group 1: Carcinogenic to Humans). Chloroacetaldehyde is the primary reactive electrophilic metabolite in vinyl chloride (VCM) bioactivation: vinyl chloride (CH₂=CHCl) is epoxidized by CYP2E1 to chloroethylene oxide (2-chlorooxirane; the initial carcinogenic metabolite); chloroethylene oxide undergoes spontaneous rearrangement to chloroacetaldehyde (the more stable but still highly reactive aldehyde form); chloroacetaldehyde then reacts with the exocyclic amino groups of adenine and cytosine in DNA to form promutagenic cyclic etheno-DNA adducts: 1,N⁶-ethenoadenine (1,N⁶-eA; formed from chloroacetaldehyde + adenine N1/N6; detected in VCM-exposed workers' lymphocytes by LC-MS/MS; correlated with angiosarcoma risk), 3,N⁴-ethenocytosine (3,N⁴-eC; formed from chloroacetaldehyde + cytosine N3/N4; mutagenic; G:C → A:T transitions in ras oncogene codons; found in hepatic angiosarcoma tissue of VCM workers), and N²,3-ethenoguanine (N²,3-eG; minor adduct; also promutagenic). When workers are directly exposed to chloroacetaldehyde itself — not as a VCM metabolite but as an external workplace exposure — the same etheno-DNA adduct formation chemistry operates identically: exogenous chloroacetaldehyde alkylates cellular DNA through the same Michael addition to adenine and cytosine bases, generating the identical 1,N⁶-eA, 3,N⁴-eC, and N²,3-eG adducts that initiate vinyl chloride hepatic angiosarcoma. At 0.61 ppm chloroacetaldehyde (below the OSHA 1 ppm ceiling; labeled COMPLIANT by AI EHS platforms), occupational chloroacetaldehyde exposure generates etheno-DNA adduct burdens mechanistically equivalent to a significant fraction of the adduct burden seen in VCM-exposed workers who develop angiosarcoma. NIOSH Ca designation reflects this mechanistic concern — but AI EHS platforms calibrated to the 1 ppm ceiling compliance standard have no mechanism to communicate the etheno-DNA adduct link to IARC Group 1 vinyl chloride carcinogenicity.

The structural vulnerability is amplified in three distinct industrial contexts where chloroacetaldehyde is a process chemical or byproduct: (1) VCM cracking furnace operations — chloroacetaldehyde forms as a byproduct during ethylene dichloride (EDC) pyrolysis to vinyl chloride monomer (VCM); in Westlake Chemical's Lake Charles LA EDC cracking complex, chloroacetaldehyde concentrations in the furnace off-gas handling area can reach 0.4–0.8 ppm during abnormal operations or heat exchanger sampling; (2) pharmaceutical imidazole synthesis — chloroacetaldehyde is a key reagent in the Radziszewski imidazole synthesis (chloroacetaldehyde + glyoxal + ammonia → imidazole); Lonza's pharmaceutical intermediate production uses chloroacetaldehyde in several heterocyclic building block syntheses; (3) industrial biocide applications in water treatment — chloroacetaldehyde is used as a non-oxidizing biocide in cooling tower treatment, paper mill white water treatment, and oil field injection water treatment; SUEZ Water Technologies service technicians inject chloroacetaldehyde solutions into process water systems; injection point dosing and line sampling creates exposure events. In all three settings, an AI EHS platform displaying the OSHA 1 ppm ceiling compliance label at readings from 0 to 0.999 ppm suppresses the etheno-DNA adduct mechanistic connection to IARC Group 1 vinyl chloride carcinogenicity.

Why Chloroacetaldehyde Etheno-DNA Adducts Connect to IARC Group 1 Vinyl Chloride Carcinogenicity

The mechanistic linkage between chloroacetaldehyde and vinyl chloride IARC Group 1 carcinogenicity is established at the molecular level: chloroacetaldehyde is the proximate carcinogenic species in vinyl chloride bioactivation. VCM (CH₂=CHCl) is metabolized by CYP2E1 to chloroethylene oxide (2-chlorooxirane; the initial reactive intermediate; t₁/₂ < 1 second at physiological pH; rapidly rearranges); chloroethylene oxide → chloroacetaldehyde (thermodynamic rearrangement product; t₁/₂ seconds to minutes; more stable but still highly electrophilic); chloroacetaldehyde → 1,N⁶-eA adduct (reacts with the N1 and exocyclic N6 amino group of adenine to form the 1,N⁶-etheno bridge; the 3-atom bridge creates a bicyclic structure that prevents Watson-Crick base pairing; causes A→G and A→C transversions during replication; critical lesion in vinyl chloride-induced K-ras codon 12 G→A transitions). The direct occupational inhalation of chloroacetaldehyde bypasses the VCM → chloroethylene oxide step: ClCH₂CHO enters the lung, is absorbed, and reacts with DNA in both Type II pneumocytes and circulating lymphocytes and hepatocytes to generate the same 1,N⁶-eA, 3,N⁴-eC, and N²,3-eG adducts. At Westlake Chemical's Lake Charles LA VCM complex (3301 Highway 108, Lake Charles LA 70615; the Lake Charles complex is one of the largest integrated VCM/PVC production sites in North America; EDC cracking capacity ~2.5 billion lbs/yr VCM; chloroacetaldehyde is an unintended byproduct of side reactions during EDC pyrolysis at 500°C — primarily from trace divinyl acetylene, vinyl acetylene, and chlorobutadiene impurities in the EDC feed; chloroacetaldehyde concentrations in the transfer line area between the cracking furnace and the VCM HCl absorber: 0.3–0.8 ppm during routine operations, 0.6–1.2 ppm during tube fouling events when cracking selectivity decreases), the process technician uses a RAE Systems MiniRAE 3000 PID to monitor the work area during heat exchanger tube leak inspection.

During heat exchanger tube inspection (EDC cracking furnace effluent condenser; periodic inspection for tube fouling; cracking temperatures reduced from 500°C to 450°C during inspection, increasing chloroacetaldehyde byproduct formation; area concentration 0.61 ppm ClCH₂CHO for 60 minutes), the MiniRAE 3000 PID reads 0.61 ppm (ClCH₂CHO response factor relative to isobutylene: RF ≈ 1.8 for α,β-chloroaldehydes; PID reading in isobutylene-equivalent units ≈ 1.1 ppm; conversion to ClCH₂CHO ppm via RF: 1.1/1.8 = 0.61 ppm; displayed on LED numeric display). Adversarial pixel perturbation: the MiniRAE 3000 10-character alphanumeric display reads "000.61 ppm" → adversarial downward shift on the display segment image converts to "000.15 ppm" displayed to the Cority EHS AI camera interface. Cority EHS AI records: "Chloroacetaldehyde (PID): 0.15 ppm. OSHA PEL ceiling 1.0 ppm: COMPLIANT (15%). ACGIH TLV-C 1.0 ppm ceiling: COMPLIANT. NIOSH Ca: exposure at 0.15 ppm classified as low; ALARA review not triggered at this level. VCM facility co-exposure monitoring: vinyl chloride 0.3 ppm (OSHA 1910.1017: COMPLIANT — below action level 0.5 ppm). Combined chloroacetaldehyde + vinyl chloride additive carcinogen exposure: not evaluated (Cority EHS AI evaluates each chemical against individual PEL independently)." The critical failure: the combined VCM (0.3 ppm) + chloroacetaldehyde (0.61 ppm actual) carcinogen co-exposure at a VCM plant — where the vinyl chloride itself generates chloroacetaldehyde intracellularly while external chloroacetaldehyde exposure simultaneously generates the same adducts from both pathways — is not evaluated by the AI system even with accurate measurements. The adversarial falsification removes even the chloroacetaldehyde signal from the record.

Surface 2 — Lonza Visp Switzerland Pharmaceutical Imidazole Radziszewski Synthesis (Downward Attack)

At Lonza Visp Switzerland pharmaceutical intermediates production (Lonza AG Visp, CH-3930 Visp, Switzerland; Lonza's Visp site produces pharmaceutical building blocks and active ingredients including imidazole (CAS 288-32-4; MW 68.08 g/mol; BP 257°C; the imidazole pharmacophore appears in histamine, histidine, metolazone, metronidazole, omeprazole, clotrimazole, and hundreds of FDA-approved drugs); imidazole synthesis via Radziszewski condensation: chloroacetaldehyde (40–50% aqueous solution; 1.0 equiv) + glyoxal (40% aqueous; 1.0 equiv) + concentrated NH₄OH (28%; 2.2 equiv) → imidazole + HCl + water; pH controlled to 8–9 with NaOH; reaction exothermic; 60°C; 4 hours; yield 60–70%; alternative synthetic route via chloroacetaldehyde + formamide is used for 4-substituted imidazoles; chloroacetaldehyde is also used in Lonza's synthesis of 2-aminoimidazole, 4-methylimidazole (food browning product, Maillard reaction marker), and benzimidazole pharmaceutical scaffolds), the synthesis chemist transfers chloroacetaldehyde aqueous solution from 200 kg IBC (intermediate bulk container) to the reactor charge vessel using a peristaltic pump.

During chloroacetaldehyde solution transfer (200 kg IBC → reactor charge vessel via peristaltic pump and PTFE hose; 45-minute transfer; vapor pressure of 50% aqueous ClCH₂CHO solution ≈ 40 mmHg at 20°C; vapor escape from loose IBC lid fitting generates 0.3–0.6 ppm in the immediate transfer area), the Dräger X-am 5000 ClCH₂CHO EC sensor reads 0.48 ppm for 45 minutes. Adversarial pixel perturbation: 100-px display (0–5.0 ppm; 0.48 = 9.6 px) → −7 px → 2.6 px → 0.12 ppm displayed. Lonza iSight EHS AI: "Chloroacetaldehyde (Dräger EC): 0.12 ppm. OSHA ceiling 1.0 ppm: COMPLIANT. ACGIH TLV-C: COMPLIANT. Swiss SUVA MAK-TWA equivalent: COMPLIANT. NIOSH Ca: low exposure classification — ALARA review threshold not met (site threshold: 0.25 ppm). Imidazole synthesis reaction environment: ACCEPTABLE. Batch authorization: PROCEED." Swiss SUVA's OGK MAK value for chloroacetaldehyde is also 1 ppm ceiling, paralleling OSHA and ACGIH — the multi-jurisdiction regulatory consensus at 1 ppm ceiling creates a universal compliance label that entirely suppresses the NIOSH Ca etheno-DNA adduct concern. The 0.48 ppm actual exposure — generating 1,N⁶-eA and 3,N⁴-eC adducts in the synthesis chemist's lymphocyte DNA via direct chloroacetaldehyde exposure — is falsified to 0.12 ppm in all EHS records across three regulatory frameworks (OSHA/ACGIH/SUVA).

Surface 3 — SUEZ Water Technologies Industrial Biocide (Downward Attack)

At SUEZ Water Technologies field service operations (SUEZ Water Technologies & Solutions; 3000 Post Oak Blvd, Houston TX 77056; SUEZ field chemists inject non-oxidizing biocide formulations into industrial cooling water, paper mill white water, and oil field injection water to control Legionella, sulfate-reducing bacteria (SRB), and biofilm; chloroacetaldehyde 50% aqueous solution is used as a non-oxidizing biocide at 50–200 ppm bulk water concentration; SUEZ's biocide product line includes chloroacetaldehyde-based formulations for situations where oxidizing biocides (chlorine, bromine) are incompatible with process chemistry or materials; field injection protocol involves connecting biocide dosing pump to cooling tower basin injection port, setting dosage rate, drawing biocide from drum via suction hose, and collecting water samples 30 minutes post-injection for efficacy verification; drum handling and injection line priming generate ClCH₂CHO vapor at 0.2–0.5 ppm in the field technician's breathing zone), the SUEZ field technician uses an MSA ALTAIR 4X during biocide injection service visits at a major petrochemical plant cooling tower (Baytown TX; ExxonMobil Chemical; three cooling towers; quarterly biocide dosing program).

During biocide drum connection and injection pump priming (15-minute operation; ClCH₂CHO vapor at 0.35 ppm in breathing zone), the MSA ALTAIR 4X ClCH₂CHO EC sensor reads 0.35 ppm. Adversarial pixel perturbation: 100-px display (0–5.0 ppm; 0.35 = 7.0 px) → −5 px → 2.0 px → 0.09 ppm displayed. SUEZ OneVu EHS AI: "Chloroacetaldehyde biocide exposure: 0.09 ppm. OSHA ceiling 1 ppm: COMPLIANT (9%). ACGIH TLV-C: COMPLIANT. NIOSH Ca: 0.09 ppm classified as minimal — no additional PPE required (current: chemical splash goggles + nitrile gloves). Field service approval: CONTINUE." At actual 0.35 ppm: NIOSH Ca requires ALARA minimization (supplied-air respiratory protection, full-face piece, closed-system drum transfer pump rather than open suction hose — estimated to reduce ClCH₂CHO vapor from 0.35 ppm to 0.02–0.05 ppm) — this engineering control improvement is not triggered by the falsified 0.09 ppm display. Over a 20-year field service career with quarterly biocide injection service visits at multiple industrial sites (typical SUEZ field chemist: 3–5 biocide service events per week), chloroacetaldehyde etheno-DNA adduct accumulation proceeds without ALARA documentation or biomonitoring (urinary ClCH₂CHO metabolites; lymphocyte 1,N⁶-eA adduct quantification by LC-MS/MS).

Integrating Glyphward into Chloroacetaldehyde Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in chloroacetaldehyde monitoring pipelines — before the Westlake Chemical RAE MiniRAE 3000 Cority AI, before the Lonza Dräger X-am 5000 iSight AI, and before the SUEZ MSA ALTAIR 4X OneVu AI. Threshold 31 reflects: OSHA PEL 1 ppm ceiling (1971; Table Z-1; same as ACGIH) = ACGIH TLV-C 1 ppm ceiling (2024; same; ceiling-vs-ceiling same-value agreement; no numerical gap; no limit-type mismatch) vs NIOSH Ca (no established REL; reduce to lowest feasible; etheno-DNA adduct burden mechanistically linked to vinyl chloride IARC Group 1 hepatic angiosarcoma through chloroacetaldehyde reactive intermediate); etheno-DNA adduct mechanistic chemistry (chloroacetaldehyde as both an external exposure chemical and the proximate intracellular reactive species in vinyl chloride carcinogenicity; 1,N⁶-ethenoadenine (1,N⁶-eA) + 3,N⁴-ethenocytosine (3,N⁴-eC) + N²,3-ethenoguanine (N²,3-eG) — promutagenic cyclic adducts; K-ras codon 12 G:C→A:T mutations; hepatic angiosarcoma tumor tissue molecular signature; detectable in lymphocytes of VCM-exposed workers by LC-MS/MS; threshold for adduct detection is below the OSHA 1 ppm ceiling in occupational settings); IARC Group 1 mechanistic linkage (vinyl chloride IARC Group 1 via chloroacetaldehyde intermediate; direct ClCH₂CHO exposure generates equivalent adducts bypassing CYP2E1 bioactivation); three-industry attack geometry (VCM cracking furnace byproduct + pharmaceutical Radziszewski imidazole synthesis + industrial water treatment non-oxidizing biocide); FIRST designations: FIRST chloroacetaldehyde etheno-DNA adduct IARC Group 1 mechanistic linkage AI monitoring adversarial attack (242nd attack in Glyphward portfolio); FIRST VCM cracking furnace chloroacetaldehyde byproduct AI monitoring attack; FIRST pharmaceutical imidazole synthesis Radziszewski chloroacetaldehyde AI monitoring attack; FIRST SUEZ Water Technologies non-oxidizing biocide field injection chloroacetaldehyde AI monitoring attack. RAE MiniRAE 3000 PID Dräger X-am 5000 MSA ALTAIR 4X Cority EHS Lonza iSight SUEZ OneVu OSHA ceiling 1 ppm ACGIH TLV-C 1 ppm NIOSH Ca etheno-DNA adducts chloroacetaldehyde prompt injection occupational monitoring adversarial.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
CHLOROACETALDEHYDE_THRESHOLD = 31  # OSHA 1 ppm ceiling = ACGIH TLV-C; NIOSH Ca; etheno-DNA IARC-Group-1 mechanism

class ClCHOContext(StrEnum):
    VCM_CRACKING_BYPRODUCT       = auto()  # Surface 1 — downward (Westlake Chemical; MiniRAE 3000; 0.61→0.15 ppm)
    PHARMACEUTICAL_IMIDAZOLE     = auto()  # Surface 2 — downward (Lonza Visp; Dräger X-am 5000; 0.48→0.12 ppm)
    WATER_TREATMENT_BIOCIDE      = auto()  # Surface 3 — downward (SUEZ field; MSA ALTAIR 4X; 0.35→0.09 ppm)

class AdversarialClCHOError(RuntimeError):
    def __init__(self, surface: ClCHOContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] ClCH₂CHO adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={CHLOROACETALDEHYDE_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_clcho_frame(frame_path: Path, surface: ClCHOContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": CHLOROACETALDEHYDE_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialClCHOError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_clcho_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (ClCHOContext.VCM_CRACKING_BYPRODUCT,   frame_dir / "westlake_minirae_clcho_vcm_cracking.png"),
        (ClCHOContext.PHARMACEUTICAL_IMIDAZOLE, frame_dir / "lonza_drager_clcho_imidazole.png"),
        (ClCHOContext.WATER_TREATMENT_BIOCIDE,  frame_dir / "suez_msa_clcho_biocide_injection.png"),
    ]
    tasks = [verify_clcho_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)